source
- STAT+: French regulator fines Novo and Lilly over weight loss ad campaignsFrance's medicines regulator has fined Novo Nordisk and Eli Lilly over their weight loss ad campaigns.STAT · 2mo ago↗ source
- Opinion: Mifepristone court ruling makes drug development riskier for everyoneThe 5th Circuit’s ruling on mifepristone “is bad for health care access, and it’s also bad for innovation,” writes Grace E. Colón.STAT · 2mo ago↗ source
- Supreme Court restores access to abortion pill mifepristone through telehealth, mail, and pharmaciesThe Supreme Court on Monday restored broad access to the abortion pill mifepristone, blocking a ruling that had threatened to upend one of the main ways abortion is provided across the…STAT · 2mo ago